De novo lipogenesis represents a therapeutic target in mutant Kras non-small cell lung cancer.
Singh A, Ruiz C, Bhalla K, Haley JA, Li QK, Acquaah-Mensah G, Montal E, Sudini KR, Skoulidis F, Wistuba II, Papadimitrakopoulou V, Heymach JV, Boros LG, Gabrielson E, Carretero J, Wong KK, Haley JD, Biswal S, Girnun GD.
Singh A, et al. Among authors: haley ja, haley jd.
FASEB J. 2018 Jun 15;32(12):fj201800204. doi: 10.1096/fj.201800204. Online ahead of print.
FASEB J. 2018.
PMID: 29906244
Free PMC article.
These studies highlight the potential to target mutant Kras tumors by taking advantage of the lipogenic phenotype induced by mutant Kras.-Singh, A., Ruiz, C., Bhalla, K., Haley, J. A., Li, Q. K., Acquaah-Mensah, G., Montal, E., Sudini, K. R., Skoulidis, F., Wistuba, …
These studies highlight the potential to target mutant Kras tumors by taking advantage of the lipogenic phenotype induced by mutant Kras.-Si …